2022 Imaging Nuclear Medicine Radiation 
AuntMinnie
MARCH 7, 2024
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% from 1,401 estimated PET scans per system in 2022 to 1,495 in 2023. Want to share your knowledge of medical imaging? Want to share your knowledge of medical imaging? physicians reading PET scans per site.
AuntMinnie
SEPTEMBER 12, 2024
In 2023, RTs had an average base salary of $92,000, up from 2022's $85,238. Those who specialized -- particularly in CT, MRI, neuroimaging, and nuclear medicine/PET -- earned more. Body imaging and radiation therapy technologists came in last, with annual base salaries of $73,000. Note: Salaries are for all U.S.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
MARCH 26, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
AuntMinnie
APRIL 4, 2024
Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added.
AuntMinnie
JULY 10, 2024
The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclear medicine, and radiation oncology. Centers for Medicare and Medicaid Services (CMS) proposed Medicare Physician Fee Schedule (MPFS) 2025 rule. However, interventional radiology will have a decrease of 2%.
AuntMinnie
JANUARY 26, 2024
In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. PET/CT and MR images of a 72-year-old woman. (A)
AuntMinnie
JUNE 20, 2024
Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.
Expert insights. Personalized for you.
116 
Let's personalize your content